About this initiative
Roadmaps and inception impact assessments describe the scope, purpose and timing of new laws and policies. They also set out plans for evaluations of existing laws or ‘fitness checks’ of multiple laws.
Communication on a strategic approach to pharmaceuticals in the environment
Subscribe to receive notifications
Give your feedback
28 April 2017 - 26 May 2017
Recent feedback
-
Coalition Clean Baltic (Sweden)
Coalition Clean Baltic (Sweden)
Coalition Clean Baltic (CCB) is a regional network of grass root environmental NGOs committed to protection and improvement of the environment of the Baltic Sea catchment area. The network was established in 1990 and includes 18 member organizations representing the main largest environmental non-governmental organisations with more than 850.000 individual members in the countries within the Baltic Sea catchment area, both within and outside...
-
AEGSP (Association of the European Self-Medication Industry), EFPIA (European Federation of Pharmaceutical Industries and Associations) and Medicines for Europe (representing representing the European generic medicines and biosimilar industries) (Belgium)
AEGSP (Association of the European Self-Medication Industry), EFPIA (European Federation of Pharmaceutical Industries and Associations) and Medicines for Europe (representing representing the European generic medicines and biosimilar industries) (Belgium)
The European pharmaceutical industry represented by AESGP, EFPIA and Medicines for Europe support the Roadmap objectives of filling knowledge gaps, exploring how to protect the environment and safeguarding patient access to pharmaceutical treatments. The objectives are aligned with our Eco-Pharmaco-Stewardship (EPS) program[1,2,3]. EPS takes a life-cycle approach to PiE management and includes initiatives on managing environmental risks post...
-
Society for Applied Microbiology (United Kingdom)
Society for Applied Microbiology (United Kingdom)
I am providing feedback as a Member of the Society for Applied Microbiology Meetings Sub-Committee, to inform you that we are organising a meeting on Antimicrobial Resistance and Wastewater Treatment (see attachment), which will include treatment of antibiotic-containing wastewaters, This session will be held at Charles Darwin House, London, on Friday, November 24th, 2017 and is being organised by SfAM in collaboration with the Royal Society...
-
Huize Aarde (Netherlands)
Huize Aarde (Netherlands)
One of the first steps for a roadmap should be the use and definition of crucial concepts to be applied for policy making. With the right definition of the concepts to be used, the direction for thinking and acting will be determined. Pharmaceuticals in the environment Emphasis lies on the emission and existence of these molecules and resistant micro-organisms in a substrate. Although due to their characteristics these molecules and organisms...
-
Advanced Bioprocess Development Ltd. (United Kingdom)
Advanced Bioprocess Development Ltd. (United Kingdom)
I am providing feedback through my experience and expertise as a researcher at Manchester Metropolitan University (MMU) and Managing Director of MMU spin-out company, Advanced Bioprocess Development Ltd. (ABD). These views do not necessarily represent those of MMU. ABD has developed a tertiary process for wastewater treatment that removes ammonia, organic matter (BOD), suspended solids, coliform bacteria, and oestrogens E1, E2 & EE2. It is...
-
Baltic Sea Centre, Stockholm University (Sweden)
Baltic Sea Centre, Stockholm University (Sweden)
We welcome the Commission’s initiative to reduce harmful effects of pharmaceuticals in the environment and believe that the issue needs to be addressed at several stages of the lifecycle of a pharmaceutical substance. Important upstream measures include facilitating for public procurement to put requirements on ERA for products and withdrawing OTC status for APIs with negative environmental effects (e.g. Diclofenac). The actual reduction...